Kim et al. [54] detected ∼40.4% (42/104) patients with promoter methylation of EBF3, and the promoter methylation linked with lymphatic invasion (P=0.013) and poor survival (P=0.038) in GC. The gene discussed is EBF3; the disease is gastric cancer.